Cefazolin sodium salt CAS:27164-46-1
Cefazolin sodium salt is a vital antibiotic utilized in healthcare settings to combat bacterial infections. It is frequently prescribed to treat skin and soft tissue infections, urinary tract infections, respiratory tract infections, surgical site infections, and other susceptible bacterial diseases. Healthcare providers determine the appropriate dosage, frequency, and duration of cefazolin therapy based on the type of infection, the identified pathogen, and individual patient factors. Intravenous or intramuscular administration of cefazolin allows for rapid and effective delivery of the medication, making it suitable for both hospitalized patients and outpatient treatment. Close monitoring for potential side effects, such as allergic reactions or gastrointestinal disturbances, is essential during cefazolin therapy. Patients receiving cefazolin are advised to adhere strictly to the prescribed treatment regimen and complete the full course of antibiotics as directed by healthcare professionals. This helps ensure the eradication of the infectious agent and reduces the risk of recurrent infections or antibiotic resistance development. Collaboration between healthcare providers and patients, along with vigilant monitoring throughout treatment, supports the safe and effective use of cefazolin sodium salt in managing bacterial infections while striving for optimal clinical outcomes and patient well-being.
Composition | C14H15N8NaO4S3 |
Assay | 99% |
Appearance | white powder |
CAS No. | 27164-46-1 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |